Showing results (1101-1110 of 3,550) with videos related to
Sort By:
Pageof 355
Thoracic Cancer|May 21, 2025
Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR-Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort StudyMi-Hyun Kim, Min Ki Lee, Ji Eun Park, et al.Thoracic Cancer|May 14, 2025
Prognostic Significance, Radiological, and Metabolic Characteristics of Metastatic Lymph Nodes in Resectable Non-Small Cell Lung Cancer Following Neoadjuvant ChemoimmunotherapyTianxiao Han, Sida Cheng, Xun Wang, et al.Thoracic Cancer|August 22, 2025
Three-Year Follow-Up of the Phase II Trial for Resectable Non-Small-Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD-NeoFOUR TrialZhiyuan Gao, Yajie Mao, Yichen Sun, et al.Thoracic Cancer|February 1, 2026
A Novel Intra-Operative Irrigation-Drainage System for Robot-Assisted Thoracoscopic Esophagogastric Layered Anastomosis: Preliminary Practice and Short-Term Clinical OutcomesChuan Zhong, Lian Li, Zun Wang, et al.Thoracic Cancer|January 19, 2026
Risk Factors of Hematological Toxicity of Mesothelioma Treatment-A Territory-Wide Retrospective StudyWang Chun Kwok, Desmond Yat Hin Yap, Isaac Sze Him Leung, et al.Thoracic Cancer|March 25, 2025
One-Stage Bilateral Pulmonary Nodule Resection via Unilateral Thoracic Cavity Access: A Single-Center Experience of 12 CasesZhen Wang, Zhaolei You, Yingjian Song, et al.Thoracic Cancer|March 24, 2025
Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in JapanSatoshi Miyamoto, Akihiro Tsukaguchi, Hanako Kuhara, et al.Thoracic Cancer|March 21, 2025
ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab MonotherapyFranziska Certa, Peter A Horn, Julius Keyl, et al.Thoracic Cancer|March 21, 2025
Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single-Arm StudyXiaoyi Feng, Xiaoyan Liu, Hui Guan, et al.Thoracic Cancer|March 20, 2025
Identifying Lipid Metabolism-Related Therapeutic Targets and Diagnostic Markers for Lung Adenocarcinoma by Mendelian Randomization and Machine Learning AnalysisSu Wei, Zhou Guangyao, Tian Xiangdong, et al.Pageof 355